Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
Pallavi Chaturvedi, … , Andre Levchenko, Gregg L. Semenza
Pallavi Chaturvedi, … , Andre Levchenko, Gregg L. Semenza
Published December 17, 2012
Citation Information: J Clin Invest. 2013;123(1):189-205. https://doi.org/10.1172/JCI64993.
View: Text | PDF | Corrigendum
Research Article

Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis

  • Text
  • PDF
Abstract

Metastasis involves critical interactions between cancer and stromal cells. Intratumoral hypoxia promotes metastasis through activation of hypoxia-inducible factors (HIFs). We demonstrate that HIFs mediate paracrine signaling between breast cancer cells (BCCs) and mesenchymal stem cells (MSCs) to promote metastasis. In a mouse orthotopic implantation model, MSCs were recruited to primary breast tumors and promoted BCC metastasis to LNs and lungs in a HIF-dependent manner. Coculture of MSCs with BCCs augmented HIF activity in BCCs. Additionally, coculture induced expression of the chemokine CXCL10 in MSCs and the cognate receptor CXCR3 in BCCs, which was augmented by hypoxia. CXCR3 expression was blocked in cocultures treated with neutralizing antibody against CXCL10. Conversely, CXCL10 expression was blocked in MSCs cocultured with BCCs that did not express CXCR3 or HIFs. MSC coculture did not enhance the metastasis of HIF-deficient BCCs. BCCs and MSCs expressed placental growth factor (PGF) and its cognate receptor VEGFR1, respectively, in a HIF-dependent manner, and CXCL10 expression by MSCs was dependent on PGF expression by BCCs. PGF promoted metastasis of BCCs and also facilitated homing of MSCs to tumors. Thus, HIFs mediate complex and bidirectional paracrine signaling between BCCs and MSCs that stimulates breast cancer metastasis.

Authors

Pallavi Chaturvedi, Daniele M. Gilkes, Carmen Chak Lui Wong, Kshitiz, Weibo Luo, Huafeng Zhang, Hong Wei, Naoharu Takano, Luana Schito, Andre Levchenko, Gregg L. Semenza

×

Figure 2

HIFs mediate coculture- and hypoxia-induced CXCL10, CXCR3, CCL5, and CCR5 expression.

Options: View larger image (or click on image) Download as PowerPoint
HIFs mediate coculture- and hypoxia-induced CXCL10, CXCR3, CCL5, and CCR...
(A–D) BCCs, MSCs, or BCCs+MSCs were cultured at 20% or 1% O2 for 48 hours, and CXCL10 (A), CXCR3 (B), CCL5 (C), and CCR5 (D) mRNA levels were determined by RT-qPCR (mean ± SEM; n = 3). Levels were normalized to BCCs at 20% O2. *P < 0.05 vs. 20% BCCs or 20% MSCs; #P < 0.01, ##P < 0.001 vs. 20% BCCs+MSCs, 1-way ANOVA. (E and F) EV cells, DKD cells, EV+MSCs, or DKD+MSCs were cultured at 20% or 1% O2 for 48 hours. CXCL10 and CXCR3 mRNA levels were analyzed by RT-qPCR and normalized to those in EV cells at 20% O2 (mean ± SEM; n = 3). *P < 0.05 vs. 20% EV+MSCs; **P < 0.001 vs. 1% EV+MSCs, 1-way ANOVA. (G and H) GFP-expressing BCCs were cocultured with MSCs at 20% or 1% O2 for 48 hours, then subjected to FACS based on GFP fluorescence for BCCs and CD105 immunofluorescence for MSCs. CXCR3 and CXCL10 mRNA levels were determined in flow-sorted BCCs and MSCs. BCCs and MSCs cultured alone were used as controls. Levels were normalized to BCCs at 20% O2. *P < 0.01 vs. 20% MSCs or BCCs alone; #P < 0.001 vs. 1% MSCs or BCCs alone, 1-way ANOVA.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts